Read More Pharma Industry News Can Camurus’ once-monthly semaglutide depot reshape the future of obesity and diabetes treatment? Camurus reports positive Phase 1b results for CAM2056, a monthly semaglutide depot, showing 9.3% weight loss and strong A1c reduction. Read the full data. bySrinathNovember 11, 2025